Ocuphire Pharma Inc (NASDAQ:OCUP)

2.97
Delayed Data
As of Dec 01
 -0.08 / -2.62%
Today’s Change
2.48
Today|||52-Week Range
6.60
-15.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization27.5K32.9K42.4K48.2K
 
 
 
 
 
 
Operating ExpensesGross Income-27.5K-32.9K-42.4K-48.2K
 
 
 
 
 
General Expenses18.2M16.4M17.3M20.5M
 
 
 
 
 
Research And Development12.1M10.1M10.7M13.1M
 
 
 
 
 
Total Operating Expenses18.3M16.4M17.4M20.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-18.3M-16.4M-17.4M-20.5M
 
 
 
 
 
Extraordinary Credit4.0M7.3M0.005.5M
 
 
 
 
Extraordinary Charge0.000.00-7.6M0.00
 
 
Interest Expense On Debt0.00313.1K0.000.00
 
 
Other Expenses-211.1K0.00-552.6K368.8K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.4M-9.3M-25.3M-14.4M
 
 
 
 
 
Net Income-14.4M-9.3M-25.3M-14.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.5M1.8M2.3M2.7M
 
 
 
 
 
Shares To Calculate EPS Diluted1.5M1.8M2.3M2.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$9.60-$4.80-$11.04-$5.28
 
 
 
 
 
EPS Diluted-$9.60-$4.80-$11.04-$5.24